Stockreport

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Conco...

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com
PDF – Post-hoc analysis from pivotal Phase 3 REST-ON trial confirmed the efficacy of LUMRYZ in study participants who were and were not using a stable dose of an alerting ag [Read more]